February 1, 2017
Biomarin’s hemophilia drug nets PRIME status in Europe
BioMarin Pharmaceutical’s treatment for hemophilia has been accepted for PRIME (Priority Medicines) scheme from the European Medicines Agency (EMA).
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
February 1, 2017
Ineos Styrolution presents two new styrenics grades at Pharmapack 2017, Paris
INEOS Styrolution, the global player in styrenics, has announced two new styrenics grades, both of which designed for very specific use by medical device manufacturers.
February 1, 2017
INTERVIEW: Anne Schumacher, Brand Director at Pharmapack Europe, 20 years of Pharmapack
Pharmapack 2017, kicking off on February 1, 2017 marks 20 years of Pharmapack. We talked with Anne Schumacher, Brand Director at Pharmapack Europe.
February 1, 2017
Allergy Therapeutics’s peanut allergy vaccine research shows positive results
Allergy Therapeutics, a pharmaceutical company specialising in allergy vaccines, has announced positive results from preclinical research of its therapeutic peanut allergy vaccine, Polyvac Peanut.
February 1, 2017
Sanofi wins approval for its two drugs in North America
Sanofi announced on Wednesday two approvals for its drugs in North America. Rheumatoid arthritis drug, which it has made in cooperation with Regeneron Pharmaceuticals, has been approved by Health Canada and the U.S. Food and Drug Administration (FDA) has approved Xyzal Allergy 24HR
February 1, 2017
Big pharma CEO’s after meeting with Trump: Fixing policies could create 350000 jobs in 10 years
Several leaders of some of the largest pharmaceutical companies have met on Tuesday with the newly elected US president, Donald Trump to discuss industry related topics, agreeing that the talks were positive.
February 1, 2017
Akers Biosciences expects 66% revenue increase, falls short in China
Akers Biosciences, a developer of rapid health information technologies, expects the total revenue for the 2016 year to be about…
January 31, 2017
Failure of malaria drug “early warning” for Africa, researchers say
A drug widely used to cure malaria has failed for the first time in patients being treated in Britain, raising questions over whether the parasite is becoming resistant to drugs, researchers said on Tuesday
January 31, 2017
Trump pushes drugmakers for lower prices, more U.S. production
U.S. President Donald Trump in a meeting on Tuesday with pharmaceutical executives called on them to manufacture more of their drugs in the United States and cut prices, while vowing to speed approval of new medicines and ease regulation.
January 31, 2017
Trump wants drugmakers to produce in US, calls for quicker drug approval
The newly appointed president of the United States of America, Donald Trump said that he wants pharmaceutical companies to manufacture their products in America, during the meeting he held with leaders of some of the major drugmakers.